Osaka, Japan

Takashi Naka

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Mitsubishi Tanabe Pharma Corporation. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takashi Naka. Retrieved from https://idiyas.com/inventor/takashi-naka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takashi Naka: Innovator in Chemical Production

Introduction

Takashi Naka is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of chemical production, particularly through his innovative methods. His work focuses on enhancing production efficiency while minimizing byproducts.

Latest Patents

One of Takashi Naka's notable patents is the production method of 4-alkoxy-3-(trifluoromethyl)benzyl alcohol. This invention relates to a method that achieves a high conversion ratio while strictly suppressing the production of byproducts. The process utilizes DIBAL as a reducing agent, showcasing Naka's expertise in chemical engineering.

Career Highlights

Takashi Naka is currently associated with Mitsubishi Tanabe Pharma Corporation, where he continues to develop and refine his innovative techniques. His work has garnered attention for its practical applications in the pharmaceutical industry.

Collaborations

Throughout his career, Naka has collaborated with esteemed colleagues such as Makoto Kawano and Mitsuharu Nakamura. These partnerships have contributed to the advancement of their shared goals in chemical innovation.

Conclusion

Takashi Naka's contributions to chemical production exemplify the impact of innovative thinking in the industry. His dedication to improving production methods continues to influence the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…